Antibiotic resistance of Pseudomonas aeruginosa strains-intracellular metabolomics analysis

Area of Science:

• Microbiology and Infectious Diseases
• Metabolomics and Cheminformatics
• Molecular Biology and Biochemistry

Background:

• Pseudomonas aeruginosa (Pa) is a critical multidrug-resistant pathogen, posing significant challenges in treating bacterial infections, particularly in cystic fibrosis patients.
• Understanding the molecular mechanisms of antibiotic resistance is crucial for developing effective therapeutic strategies.
• Metabolomics offers a promising avenue for identifying novel biomarkers associated with antibiotic resistance.

Purpose of the Study:

• To investigate alterations in intracellular metabolite profiles of clinical Pseudomonas aeruginosa isolates.
• To correlate observed metabolic changes with distinct antibiotic resistance profiles.
• To identify potential novel metabolite markers for antibiotic resistance in Pa.

Main Methods:

• Intracellular metabolites were extracted from cultured Pa strains.
• Liquid Chromatography-Mass Spectrometry (LC-MS) was employed for metabolite profiling.
• Statistical and chemometric analyses were utilized to interpret the metabolomic data.

Main Results:

• A total of 45 intracellular metabolites were identified.
• Significant metabolic variations were observed across strains exposed to 14 different antibiotics.
• Alterations were predominantly noted in amino acid pathways and their derivatives, with distinct sample clustering based on antibiotic treatment.

Conclusions:

• The study identified significant shifts in bacterial metabolic pathways associated with antibiotic resistance in Pseudomonas aeruginosa.
• These metabolic alterations provide a foundation for discovering novel antibiotic resistance markers.
• Further research into these metabolic dynamics can enhance our understanding and combatting of antibiotic resistance in bacteria.